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Abstract
Hexabromocyclododecane (HBCD) is a widely utilised brominated flame retardant (BFR). It has been shown to bio-accumulate within organisms, including man, and possibly cause neurological disorders. The acute neurotoxicity of HBCD, and 6 other unrelated BFRs, were assessed in SH-SY5Y human neuroblastoma cells by 24 hour viability assays and HBCD proved to be the most lethal (LC50, 3µM). In addition, the effects of these BFRs were also assessed for their potency at inhibiting the sarcoplasmic-endoplasmic reticulum Ca 2+ ATPase (SERCA) derived from the SH-SY5Y cells and again HBCD was the most potent (IC50, 2.7µM). The data for the other BFRs tested showed a direct correlation (coefficient 0.94) between the potencies of inducing cell death and inhibiting the Ca 2+ ATPase, indicating that SERCA is likely to be the molecular target for acute toxicity. Mechanistic studies of HBCD on the Ca 2+ ATPase suggest that it affects ATP binding, phosphorylation as well as the E2 to E1 transition step.
Introduction
Ca 2+ is a commonly employed signal within cells that regulates many different cellular processes such as contraction, secretion, neurotransmission, proliferation and death by increasing intracellular Ca 2+ concentrations ([Ca 2+ ]i) levels [1] . Inadequate or prolonged elevation of [Ca 2+ ]i may lead to deleterious effects [1] and to avoid these effects, [Ca 2+ ]i levels must be strictly controlled by a variety of Ca 2+ transporters including the sarcoplasmic-endoplasmic reticulum Ca 2+ ATPase (SERCA) Ca 2+ pumps [1, 2] , which help to maintain low cytosolic [Ca 2+ ] levels. Therefore agents which have inhibitory affects on these Ca 2+ pumps will have harmful consequences to cells and tissues [2] .
1,2,5,6,9,10-Hexabromocyclododecane (HBCD) is a cyclic aliphatic brominated flame retardant (BFR) and is one of the major BFRs produced and used today. The main application of HBCD is in polystyrene foam that is used in thermal insulation of building materials, electronics, textiles and upholstered furniture.
A number of brominated flame retardants (BFRs), including 1,2,5,6,9,10-hexabromocyclododecane (HBCD), have recently been recognized as widespread environmental contaminants which are able to bio-accumulate within living organisms, including man [3] . In humans, the major intake of HBCD is from food, indoor air and dust [4] . High concentrations of up to 19200 ng/g lipid weight (lw)
were found in the blood of birds of prey (equivalent to 12 µM) and more than 9600 ng/g Iw in marine mammals (equivalent to 6 µM) [5] . In addition, concentrations of 850 ng/g lw (equivalent to 0.5 μM) were found in some human blood samples [6] as well as also being reported in human milk [7] . A number of BFRs including HBCD have been shown to be specifically neurotoxic in nature, causing neuronal cell death [3, 8] and having detrimental effects on brain development, leading to adverse effects on behaviour, learning and memory [9] . [8, 10, 11] .
It is now evident that a number of BFRs are cytotoxic at low µM concentrations within cells by altering intracellular [Ca 2+ ] levels [8, [11] [12] [13] . This has led us to investigate the effects of HBCD on SERCA Ca 2+ pumps in order to determine the likelihood of it being the molecular target for acute toxicity and additionally elucidate the molecular mechanism by which this BFR causes its effect upon this Ca 2+ transporter.
Materials and Methods

Chemicals
1,2,5,6,9,10-Hexabromocyclododecane (HBCD) (purity > 95%, commercial grade which is typically 82% -isomer and 12% -isomer), Dibromobiphenyl (DBBP) (98% purity), decabromodiphenyl ether (DBPE) (>99% purity) and tetrabromobisphenol-A diallyl ether (TBBPA-DAE) (>99% purity) were purchased from Sigma-Aldrich Co. and the volume of DMSO did not exceed 1% of the total volume added to cells, which had little effect on viability. Cell viability was determined by MTT assay, using thiazolyl blue tetrazolium bromide (MTT reagent) as described in [11] . Viable cells form an intracellular formazan product when incubated with MTT reagent for 2-3h, and this product was then solubilised with 1ml acidic isopropanol and quantified spectroscopically by measuring the difference in absorbance (Δ A =A570-A650) and compared to cells not exposed to compounds (but with up to 1% DMSO alone).
Membranes preparation
SR Ca
2+
-ATPase were prepared from rabbit skeletal muscle as described by Michelangeli and Munkonge (1991) [14] . Microsomal membranes were prepared from SH-SY5Y cells as described in [8] . Briefly, SH-SY5Y cells (1x10 6 cells/cm 2 )
detached from the tissue flask, harvested by centrifugation at 1,000g for 10 min 4°C
and washed with PBS. They were homogenized using a Teflon Potter-Elvejem homogenizer in 10 vol. of buffer containing 300 mM sucrose and 5 mM Hepes, pH 7.2, in the presence of 0.1 mM PMSF, 10 µM leupeptin and 100 µM benzamidine, and then centrifuged for 10 min at 1000 g. The pellet was resuspended in 5 vol. of the same buffer re-homogenized and centrifuged as above. The resulting supernatants were pooled and centrifuged for 20 min at 10,000 g. The supernatant from this stage was centrifuged for 1 h at 100,000 g and the resulting pellet (microsomal membrane)
was re-suspended in fresh Hepes / sucrose buffer, snap-frozen in liquid nitrogen and stored at -80 °C until use.
2.5 Measurement of the Ca 2+ -ATPase activity
The ATPase activity of the SR Ca 2+ ATPase was monitored using the coupled enzyme assay where the oxidation of NADH is coupled to hydrolysis of ATP via pyruvate kinase and lactate dehydrogenase, as described in [14, 15] ] was used. All three components are required in the assay in order to measure detectable levels of activity.
The Ca 2+ -dependent ATPase activity of SH-SY5Y cell microsomal membranes was performed using the phosphate liberation assay as described in Wootton and
Michelangeli (2006) Ammonium molybdate (25 µl of 5% (w/v)) was then added, followed by the addition on 25 µl of p-methyl-aminophenol sulphate solution (2% (w/v) containing 5% (w/v) sodium sulphate). The samples were mixed and the blue colouration was allowed to develop for 10 min prior to measuring the absorption at 870 nm using a Dynatech
Laboratories ELISA plate reader. The amount of Pi liberated was determined by comparison with known phosphate standards. The activities were also determined in the absence of Ca 2+ (1mM EGTA) to determine non Ca 2+ -dependent ATPase activity.
Phosphorylation studies
Phosphorylation of SR Ca 2+ ATPase by [γ -32 P] ATP was carried out at 25 °C as described in [2] . The SERCA was diluted to 0.1 mg/ml in 40 mM Hepes/Tris (pH 7.2) containing 100 mM KCl, 5 mM MgSO4, 1 mM CaCl2, BSA (final conc. 1 mg/ml) and 12.5 μg/ml A23187 in a total volume of 1 ml. The reaction was started by the addition of [γ - Figure 1A shows effect of HBCD on the skeletal muscle SR SERCA 1A isoform of Ca 2+ -ATPase activity, measured at pH 7.2 at 25°C. HBCD inhibits the Ca 2+ -ATPase with an IC50 values calculated to be 2.7 ± 0.6 µM. Figure 1A also shows the effects of HBCD on Ca 2+ -ATPase activity in SH-SY5Y neuronal cell microsomal membranes which expresses mainly SERCA isoform 2B [18] . The IC50 value for inhibition was similar to that of skeletal muscle SERCA 1A, indicating that the inhibition of the Ca
Results
Inhibition of Ca 2+ -ATPase activity and correlation with cell viability
2+
ATPase was not isoform-specific. Figure 1B shows As there is little difference in the potency of HBCD in inhibiting both the SERCA 1A isoform found abundantly in skeletal muscle and the SERCA 2B isoform found in neuronal cells, the highly abundant skeletal muscle form was used to further determine of the mode of inhibition of HBCD. Figure 2A shows 
The effects of HBCD on the E2 / E1 transition step
To determine whether HBCD affects the E2 / E1 step of the Ca 2+ ATPase, the conformational changes of this step was determined by monitoring the Ca 2+ -induced changes in fluorescence of Ca 2+ -ATPase labelled with FITC [17] . This was measured upon the addition of 400 µM Ca 2+ at pH 6, 25 °C where the enzyme is predominately in the E2 form [17] . Figure 4 shows the effects of HBCD on FITC-labelled Ca 2+ -ATPase when Ca 2+ is added. The addition of Ca 2+ leads to a decrease in fluorescence of 7% in the absence of HBCD corresponding to the ATPase shifting from an E2 state to the Ca 2+ bound E1 state. In the presences of 2 and 10µM HBCD, the fluorescence change was reduced to 4.6% and 0.8%, respectively. Also the rate of change in the presence 2 µM HBCD was considerably reduced compared to control. These results indicate that HBCD binds to Ca 2+ -ATPase, stabilizing it in the E2 conformational state and dramatically slowing down its transition from the E2 to E1 states.
Discussion
In previous studies by our group we have shown that HBCD and TBBPA are able to induce cell death in a number of cell types via apoptosis through the intrinsic pathway, as determined by mitochondrial membrane depolarization, mitochondrial release of cytochrome c, and activation of caspase 9 [8, 11] . All of these processes occur at similar concentration ranges, which also cause transient increases in intracellular [Ca 2+ ] (in the presence or absence of external Ca 2+ ), as well as inhibition of SR /ER Ca 2+ ATPase activity, which are factors known to induce intrinsic apoptosis through the processes highlighted above [2, 8, 11, 20] . These observations therefore lead us to conclude that acute exposure of cells to HBCD and TBBPA, causes cell death through inhibiting the SERCA Ca 2+ pumps. Here we have extended the range of BFRs studied and again show a direct correlation between potency at inducing cell death and potency at inhibition SERCA, suggesting that SERCA inhibition is a major molecular mechanism by which acute exposure to a diverse range of BFRs causes cell death.
HBCD is shown to be a potent inhibitor of both the SERCA 1A and SERCA 2B [21] .
In order to elucidate the molecular mechanism by which HBCD inhibits the Ca
2+
ATPase a detailed enzymological study was undertaken using the highly abundant and easily purified skeletal muscle Ca 2+ ATPase (SERCA 1A) isoform, which shows the same mechanism and has similar inhibitor properties to that of SERCA 2B [16, 20] .
The catalysis and transport mechanism of SERCA is complex and involves alternation between two major conformational states, known as E1(which is a high affinity Ca 2+ binding state) and E2 (which is a low affinity Ca 2+ binding state) [22] driven by transient auto-phosphorylation steps (see fig. 5 ) .
From the activity versus [ATP] data in fig. 2B , it was inferred that HBCD could potentially be affecting the affinity for ATP binding. This is further supported in fig. 3 by 32 P-ATP phosphorylation studies which also showed a reduction in ATPdependent phosphorylation consistent with a decrease in ATP affinity of the Ca In previous studies investigating the effects of hydrophobic inhibitors on the activity of the Ca 2+ ATPase such as nonylphenol, BHQ and TBBPA, we demonstrated that one of the key steps affected was the E2-E1 transition [2, 17, 20] . In this study we also showed similar results, indicating that HBCD also stabilizes the Ca 2+ ATPase in an E2
conformation by affecting both the E1 / E2 equilibrium position and rate at which the ATPase proceeds from the E2 state back to the E1 (step B in fig. 5 ). It has been previously shown that small inhibitors like BHQ, which also stabilizes the E2 state [20] , bind within a hydrophobic cavity within the transmembrane domain formed by helices 1, 3 and 4 [2, 20] , which may also be where HBCD could bind.
In this study we have used commercial grade HBCD which consists of 3 main isomers (α, β and γ) [23] , with the most abundant of these isomers being γ (~82%) followed by α (~12%). Recent studies have shown that the α isomer seems to be preferentially absorbed within the brains of mice, while juvenile mice can accumulate detectable levels of both α and γ [24, 25] . Therefore future studies would need to determine whether these different isomers have different potencies at inhibiting SERCA and causing cell death.
Conclusion
In summary, there appears to be a good direct correlation for a number of unrelated BFRs including HBCD, between their potency at inducing cell death in SH-SY5Y neuronal cells and their ability to inhibit the activity of their SERCA Ca 2+ -ATPase.
This correlation is likely to indicate that, at least for some BFRs, acute toxicity is likely to be through inhibition of SERCA and disturbance of intracellular Ca 2+ homeostasis. The molecular mechanism by which HBCD inhibits the Ca 2+ ATPase is by altering ATP binding / phosphorylation and affecting the E2 to E1 transition step. The figure shows the mechanism by which the Ca 2+ ATPase transports Ca 2+ and hydrolyses ATP, and highlights the steps (ATP binding; A, and the E2 to E1 transition; step B) that are proposed to be altered in the presence HBCD. 
